Ontario Teachers Pension Plan Board boosted its position in shares of Henry Schein, Inc. (NASDAQ:HSIC - Free Report) by 797.9% in the first quarter, according to the company in its most recent disclosure with the SEC. The firm owned 37,543 shares of the company's stock after purchasing an additional 33,362 shares during the quarter. Ontario Teachers Pension Plan Board's holdings in Henry Schein were worth $2,571,000 as of its most recent SEC filing.
A number of other institutional investors have also recently bought and sold shares of the company. Palestra Capital Management LLC acquired a new position in shares of Henry Schein in the fourth quarter valued at approximately $182,988,000. Steadfast Capital Management LP boosted its holdings in shares of Henry Schein by 254.2% in the fourth quarter. Steadfast Capital Management LP now owns 1,637,808 shares of the company's stock valued at $113,336,000 after buying an additional 1,175,408 shares during the period. Hudson Bay Capital Management LP boosted its holdings in shares of Henry Schein by 102.1% in the fourth quarter. Hudson Bay Capital Management LP now owns 1,465,007 shares of the company's stock valued at $101,378,000 after buying an additional 740,007 shares during the period. Raymond James Financial Inc. acquired a new position in shares of Henry Schein in the fourth quarter valued at approximately $34,720,000. Finally, Ananym Capital Management LP bought a new stake in shares of Henry Schein in the fourth quarter worth $32,628,000. Institutional investors and hedge funds own 96.62% of the company's stock.
Analyst Ratings Changes
A number of brokerages have recently commented on HSIC. Baird R W lowered shares of Henry Schein from a "strong-buy" rating to a "hold" rating in a research report on Monday, July 14th. Wall Street Zen lowered shares of Henry Schein from a "buy" rating to a "hold" rating in a research report on Thursday, April 17th. Stifel Nicolaus reissued a "hold" rating and issued a $75.00 price objective (down previously from $80.00) on shares of Henry Schein in a research report on Friday, July 25th. Leerink Partners set a $75.00 price objective on shares of Henry Schein in a research report on Monday, July 14th. Finally, JPMorgan Chase & Co. cut their price objective on shares of Henry Schein from $80.00 to $76.00 and set an "overweight" rating on the stock in a research report on Thursday. Nine research analysts have rated the stock with a hold rating and four have assigned a buy rating to the company. Based on data from MarketBeat.com, Henry Schein has a consensus rating of "Hold" and a consensus target price of $75.58.
Check Out Our Latest Report on HSIC
Henry Schein Stock Performance
Shares of NASDAQ:HSIC traded up $0.04 on Friday, hitting $65.94. The company had a trading volume of 1,931,964 shares, compared to its average volume of 2,156,766. Henry Schein, Inc. has a 1-year low of $60.56 and a 1-year high of $82.49. The stock has a market cap of $8.00 billion, a price-to-earnings ratio of 21.27, a P/E/G ratio of 2.17 and a beta of 0.81. The stock has a 50 day moving average price of $71.07 and a 200 day moving average price of $71.12. The company has a current ratio of 1.41, a quick ratio of 0.75 and a debt-to-equity ratio of 0.51.
Henry Schein (NASDAQ:HSIC - Get Free Report) last released its quarterly earnings data on Tuesday, August 5th. The company reported $1.10 EPS for the quarter, missing the consensus estimate of $1.19 by ($0.09). Henry Schein had a net margin of 3.05% and a return on equity of 14.36%. The company had revenue of $3.24 billion during the quarter, compared to analyst estimates of $3.22 billion. During the same quarter in the prior year, the firm earned $1.23 earnings per share. Henry Schein's revenue for the quarter was up 3.3% on a year-over-year basis. Analysts expect that Henry Schein, Inc. will post 4.74 EPS for the current year.
Henry Schein Profile
(
Free Report)
Henry Schein, Inc provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.
Featured Articles

Before you consider Henry Schein, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Henry Schein wasn't on the list.
While Henry Schein currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
With the proliferation of data centers and electric vehicles, the electric grid will only get more strained. Download this report to learn how energy stocks can play a role in your portfolio as the global demand for energy continues to grow.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.